Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

The use of neural networks in identifying risk factors for lymph node metastasis and recommending management of t1b esophageal cancer.

Sgourakis G, Gockel I, Lyros O, Lanitis S, Dedemadi G, Polotzek U, Karaliotas C, Lang H.

Am Surg. 2012 Feb;78(2):195-206. Review.

PMID:
22369829
2.

Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review.

Sgourakis G, Gockel I, Lang H.

World J Gastroenterol. 2013 Mar 7;19(9):1424-37. doi: 10.3748/wjg.v19.i9.1424. Review.

3.

Risk of lymph node metastasis in submucosal esophageal cancer: a review of surgically resected patients.

Gockel I, Sgourakis G, Lyros O, Polotzek U, Schimanski CC, Lang H, Hoppo T, Jobe BA.

Expert Rev Gastroenterol Hepatol. 2011 Jun;5(3):371-84. doi: 10.1586/egh.11.33. Review.

PMID:
21651355
4.

Prediction of lymph node status in superficial esophageal carcinoma.

Ancona E, Rampado S, Cassaro M, Battaglia G, Ruol A, Castoro C, Portale G, Cavallin F, Rugge M.

Ann Surg Oncol. 2008 Nov;15(11):3278-88. doi: 10.1245/s10434-008-0065-1. Epub 2008 Aug 26.

PMID:
18726651
5.

High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas.

Bollschweiler E, Baldus SE, Schröder W, Prenzel K, Gutschow C, Schneider PM, Hölscher AH.

Endoscopy. 2006 Feb;38(2):149-56.

PMID:
16479422
6.

Lymphatic tumor emboli detected by D2-40 immunostaining can more accurately predict lymph-node metastasis.

Moriya H, Ohbu M, Kobayashi N, Tanabe S, Katada N, Futawatari N, Sakuramoto S, Kikuchi S, Okayasu I, Watanabe M.

World J Surg. 2011 Sep;35(9):2031-7. doi: 10.1007/s00268-011-1143-2.

PMID:
21667194
7.

Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining.

Gockel I, Domeyer M, Sgourakis GG, Schimanski CC, Moehler M, Kirkpatrick CJ, Lang H, Junginger T, Hansen T.

J Surg Oncol. 2009 Sep 1;100(3):191-8. doi: 10.1002/jso.21336.

PMID:
19548259
8.

Risk factors of lymph node metastasis in T1 esophageal squamous cell carcinoma.

Kim DU, Lee JH, Min BH, Shim SG, Chang DK, Kim YH, Rhee PL, Kim JJ, Rhee JC, Kim KM, Shim YM.

J Gastroenterol Hepatol. 2008 Apr;23(4):619-25. Epub 2007 Dec 13.

PMID:
18086118
9.

Depth of submucosal tumor infiltration and its relevance in lymphatic metastasis formation for T1b squamous cell and adenocarcinomas of the esophagus.

Nentwich MF, von Loga K, Reeh M, Uzunoglu FG, Marx A, Izbicki JR, Bogoevski D.

J Gastrointest Surg. 2014 Feb;18(2):242-9; discussion 249. doi: 10.1007/s11605-013-2367-2. Epub 2013 Oct 4.

PMID:
24091912
10.

[Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].

Zhang HL, Liu RL, Shi YT, Wang ZC, Wang BH, Li YJ, Zhou LY, Ping YM.

Zhonghua Zhong Liu Za Zhi. 2009 Jul;31(7):541-5. Chinese.

PMID:
19950705
11.
12.

Prognostic impact of upper, middle, and lower third mucosal or submucosal infiltration in early esophageal cancer.

Hölscher AH, Bollschweiler E, Schröder W, Metzger R, Gutschow C, Drebber U.

Ann Surg. 2011 Nov;254(5):802-7; discussion 807-8. doi: 10.1097/SLA.0b013e3182369128.

PMID:
22042472
13.

Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.

Altorki NK, Lee PC, Liss Y, Meherally D, Korst RJ, Christos P, Mazumdar M, Port JL.

Ann Surg. 2008 Mar;247(3):434-9. doi: 10.1097/SLA.0b013e318163a2ff.

PMID:
18376186
14.

Clinicopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus.

Endo M, Yoshino K, Kawano T, Nagai K, Inoue H.

Dis Esophagus. 2000;13(2):125-9.

PMID:
14601903
15.

Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features.

Buskens CJ, Westerterp M, Lagarde SM, Bergman JJ, ten Kate FJ, van Lanschot JJ.

Gastrointest Endosc. 2004 Nov;60(5):703-10.

PMID:
15557945
16.

The overall prevalence of metastasis in T1 esophageal squamous cell carcinoma: a retrospective analysis of 295 patients.

Akutsu Y, Uesato M, Shuto K, Kono T, Hoshino I, Horibe D, Sazuka T, Takeshita N, Maruyama T, Isozaki Y, Akanuma N, Matsubara H.

Ann Surg. 2013 Jun;257(6):1032-8. doi: 10.1097/SLA.0b013e31827017fc.

PMID:
23108117
17.

The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma.

Glickman JN, Torres C, Wang HH, Turner JR, Shahsafaei A, Richards WG, Sugarbaker DJ, Odze RD.

Cancer. 1999 Feb 15;85(4):769-78.

PMID:
10091753
18.

Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors.

Tajima Y, Nakanishi Y, Ochiai A, Tachimori Y, Kato H, Watanabe H, Yamaguchi H, Yoshimura K, Kusano M, Shimoda T.

Cancer. 2000 Mar 15;88(6):1285-93.

PMID:
10717608
19.

Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma.

Estrella JS, Hofstetter WL, Correa AM, Swisher SG, Ajani JA, Lee JH, Bhutani MS, Abraham SC, Rashid A, Maru DM.

Am J Surg Pathol. 2011 Jul;35(7):1045-53. doi: 10.1097/PAS.0b013e318219ccef.

PMID:
21602659
20.

Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.

Rivadeneira DE, Simmons RM, Christos PJ, Hanna K, Daly JM, Osborne MP.

J Am Coll Surg. 2000 Jul;191(1):1-6; discussion 6-8.

PMID:
10898177
Items per page

Supplemental Content

Write to the Help Desk